Management of Vasoplegic Shock in Left Ventricular Assist Device Insertion Procedures.
作者信息
Chatterjee Subhasis
机构信息
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Texas.
出版信息
Tex Heart Inst J. 2023 Aug 8;50(4). doi: 10.14503/THIJ-23-8172.
Abstract
摘要
相似文献
1
Management of Vasoplegic Shock in Left Ventricular Assist Device Insertion Procedures.左心室辅助装置植入手术中血管麻痹性休克的管理
Tex Heart Inst J. 2023 Aug 8;50(4). doi: 10.14503/THIJ-23-8172.
2
Clinical experience with temporary right ventricular mechanical circulatory support.临时右心室机械循环支持的临床经验。
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1885-1891. doi: 10.1016/j.jtcvs.2018.04.094. Epub 2018 May 1.
3
The role of Impella percutaneous left ventricular assist device in the management of cardiogenic shock: A matter of where and when.
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):48-49. doi: 10.1002/ccd.30040.
4
Bridge to durable left ventricular assist device for refractory cardiogenic shock.桥接至耐用型左心室辅助装置治疗难治性心原性休克。
J Thorac Cardiovasc Surg. 2017 Apr;153(4):752-762.e5. doi: 10.1016/j.jtcvs.2016.10.085. Epub 2016 Nov 16.
5
Pulsus Alternans as a Sign of Right Ventricular Failure After Left Ventricular Assist Device Implantation.交替脉作为左心室辅助装置植入后右心室衰竭的体征
J Card Fail. 2020 Dec;26(12):1093-1095. doi: 10.1016/j.cardfail.2020.09.010. Epub 2020 Sep 19.
6
Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices.使用植入式左心室辅助装置改善心脏术后心源性休克的治疗效果。
Ann Thorac Surg. 1997 Dec;64(6):1757-62; discussion 1762-3. doi: 10.1016/s0003-4975(97)01107-7.
7
Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better.左心室支持用于心源性休克的治疗：尽早进行或许更佳。
JACC Cardiovasc Interv. 2021 May 24;14(10):1120-1122. doi: 10.1016/j.jcin.2021.04.016.
8
Treatment of cardiogenic shock with left ventricular assist device combined with cardiac resynchronization therapy: a case report.左心室辅助装置联合心脏再同步治疗用于心源性休克的治疗：一例病例报告
J Cardiothorac Surg. 2010 Jul 2;5:54. doi: 10.1186/1749-8090-5-54.
9
Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device.因严重急性缺血性二尖瓣反流导致的心源性休克，采用 Impella 2.5 经皮左心室辅助装置治疗。
Catheter Cardiovasc Interv. 2012 Jun 1;79(7):1129-34. doi: 10.1002/ccd.23271. Epub 2011 Oct 5.
10
Left Ventricular Assist Device Implantation As a Bailout Strategy for the Management of Refractory Electrical Storm and Cardiogenic Shock.左心室辅助装置植入作为难治性电风暴和心源性休克管理的一种补救策略。
Circ Arrhythm Electrophysiol. 2021 Oct;14(10):e009853. doi: 10.1161/CIRCEP.121.009853. Epub 2021 Sep 27.
引用本文的文献
1
Predictors and Impact of Prolonged Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation.连续流左心室辅助装置植入术后持续性血管麻痹的预测因素及影响
JACC Adv. 2024 Mar 26;3(5):100916. doi: 10.1016/j.jacadv.2024.100916. eCollection 2024 May.
本文引用的文献
1
Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care.心血管手术体外循环后的血管麻痹综合征：重症监护中的病理生理学与管理
J Clin Med. 2022 Oct 29;11(21):6407. doi: 10.3390/jcm11216407.
2
Point-of-Care Ultrasound in the Evaluation of Patients with Left Ventricular Assist Devices at the Emergency Department.急诊科应用床旁超声评估左心室辅助装置患者
J Emerg Med. 2022 Mar;62(3):348-355. doi: 10.1016/j.jemermed.2021.10.018. Epub 2022 Jan 3.
3
Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation.定义持续、连续性左心室辅助装置植入后的血管扩张症。
ASAIO J. 2022 Jan 1;68(1):46-55. doi: 10.1097/MAT.0000000000001419.
4
Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.血管扩张性休克治疗（ATHOS-3）研究的事后分析：血管扩张性心脏病手术后患者应用血管紧张素 II 治疗与血压快速反应和血管加压素节省相关。
J Cardiothorac Vasc Anesth. 2021 Jan;35(1):51-58. doi: 10.1053/j.jvca.2020.08.001. Epub 2020 Aug 7.
5
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.血管扩张性休克儿茶酚胺抵抗患者应用血管紧张素 II 治疗与肾素及生存关系的临床研究
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1253-1261. doi: 10.1164/rccm.201911-2172OC.
6
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.心胸外科手术后血管麻痹综合征：病理生理学综述及治疗选择更新。
Crit Care. 2020 Feb 4;24(1):36. doi: 10.1186/s13054-020-2743-8.
7
Risk factors for vasoplegia after cardiac surgery: a meta-analysis.心脏手术后血管麻痹的危险因素：一项荟萃分析。
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):838-844. doi: 10.1093/icvts/ivy352.
8
Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.连续流左心室辅助装置植入术后血管麻痹：发生率、结局及预测因素
BMC Anesthesiol. 2018 Dec 8;18(1):185. doi: 10.1186/s12871-018-0645-y.
9
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.血管加压素联合儿茶酚胺类血管加压药与儿茶酚胺类药物单独用于分布性休克患者心房颤动的比较：系统评价和荟萃分析。
JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528.
10
Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.左心室辅助装置植入术后血管扩张的决定因素和结果。
J Am Heart Assoc. 2018 May 17;7(11):e008377. doi: 10.1161/JAHA.117.008377.
Zotero 插件